메뉴 건너뛰기




Volumn , Issue , 2006, Pages 125-154

Glycogen Synthase Kinase 3: A Target for Novel Mood Disorder Treatments

Author keywords

Lithium molecular effects; Novel mood disorder treatment target; Thymoleptic medications on GSK 3 mediated signaling

Indexed keywords


EID: 84863003621     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470052174.ch7     Document Type: Chapter
Times cited : (3)

References (159)
  • 1
    • 0141831646 scopus 로고    scopus 로고
    • Mood disorders and medical illness: A major public health problem
    • Evans D.L., Charney D.S. (2003). Mood disorders and medical illness: A major public health problem. Biol. Psychiat., 54, 177-180.
    • (2003) Biol. Psychiat. , vol.54 , pp. 177-180
    • Evans, D.L.1    Charney, D.S.2
  • 2
    • 0035819481 scopus 로고    scopus 로고
    • Burden of disease-Implications for future research
    • Michaud C.M., Murray C.J., Bloom B.R. (2001). Burden of disease-Implications for future research. JAMA, 285, 535-539.
    • (2001) JAMA , vol.285 , pp. 535-539
    • Michaud, C.M.1    Murray, C.J.2    Bloom, B.R.3
  • 3
    • 0034158465 scopus 로고    scopus 로고
    • Searching high and low: A review of the genetics of bipolar disorder
    • Potash J.B., DePaulo J.R. Jr. (2000). Searching high and low: A review of the genetics of bipolar disorder. Bipolar Disord., 2, 8-26.
    • (2000) Bipolar Disord. , vol.2 , pp. 8-26
    • Potash, J.B.1    DePaulo Jr., J.R.2
  • 4
    • 0032803524 scopus 로고    scopus 로고
    • Genetics of bipolar disorder
    • Craddock N., Jones I. (1999). Genetics of bipolar disorder. J. Med. Genet., 36, 585-594.
    • (1999) J. Med. Genet. , vol.36 , pp. 585-594
    • Craddock, N.1    Jones, I.2
  • 5
    • 0033810465 scopus 로고    scopus 로고
    • Genetic epidemiology of major depression: Review and meta-analysis
    • Sullivan P.F., Neale M.C., Kendler K.S. (2000). Genetic epidemiology of major depression: Review and meta-analysis. Am. J. Psychiat., 157, 1552-1562.
    • (2000) Am. J. Psychiat. , vol.157 , pp. 1552-1562
    • Sullivan, P.F.1    Neale, M.C.2    Kendler, K.S.3
  • 6
    • 0033639081 scopus 로고    scopus 로고
    • Major depressive disorder
    • Fava M., Kendler K.S. (2000). Major depressive disorder. Neuron, 28, 335-341.
    • (2000) Neuron , vol.28 , pp. 335-341
    • Fava, M.1    Kendler, K.S.2
  • 8
    • 0029048116 scopus 로고
    • A pilot Swedish twin study of affective illness including hospital-and population-ascertained subsamples: Results of model fitting
    • Kendler K.S., Pedersen N.L., Neale M.C., Mathe A.A. (1995). A pilot Swedish twin study of affective illness including hospital-and population-ascertained subsamples: Results of model fitting. Behav. Genet., 25, 217-232.
    • (1995) Behav. Genet. , vol.25 , pp. 217-232
    • Kendler, K.S.1    Pedersen, N.L.2    Neale, M.C.3    Mathe, A.A.4
  • 9
    • 0032953097 scopus 로고    scopus 로고
    • Heritability of type II (non-insulin-dependent) diabetes mellitus and abnormal glucose tolerance-A population-based twin study
    • Poulsen P., Kyvik K.O., Vaag A., Beck-Nielsen H. (1999). Heritability of type II (non-insulin-dependent) diabetes mellitus and abnormal glucose tolerance-A population-based twin study. Diabetologia, 42, 139-145.
    • (1999) Diabetologia , vol.42 , pp. 139-145
    • Poulsen, P.1    Kyvik, K.O.2    Vaag, A.3    Beck-Nielsen, H.4
  • 10
    • 1542276351 scopus 로고    scopus 로고
    • Signal transduction and genesto-behaviors pathways in psychiatric diseases
    • Manji H.K., Gottesman I.I., Gould T.D. (2003). Signal transduction and genesto-behaviors pathways in psychiatric diseases. Sci. STKE, 2003, 49.
    • (2003) Sci. STKE , vol.2003 , pp. 49
    • Manji, H.K.1    Gottesman, I.I.2    Gould, T.D.3
  • 11
    • 0242322769 scopus 로고    scopus 로고
    • Epigenetics and bipolar disorder: New opportunities and challenges
    • Petronis A. (2003). Epigenetics and bipolar disorder: New opportunities and challenges. Am. J. Med. Genet., 123C, 65-75.
    • (2003) Am. J. Med. Genet. , vol.123 C , pp. 65-75
    • Petronis, A.1
  • 13
    • 0033659957 scopus 로고    scopus 로고
    • Neuroplasticity and cellular resilience in mood disorders
    • Manji H.K., Moore G.J., Rajkowska G., Chen G. (2000). Neuroplasticity and cellular resilience in mood disorders. Mol. Psychiat., 5, 578-593.
    • (2000) Mol. Psychiat. , vol.5 , pp. 578-593
    • Manji, H.K.1    Moore, G.J.2    Rajkowska, G.3    Chen, G.4
  • 14
    • 0035719852 scopus 로고    scopus 로고
    • Lithium treatment at 52
    • Schou M. (2001). Lithium treatment at 52. J. Affect. Disord., 67, 21-32.
    • (2001) J. Affect. Disord. , vol.67 , pp. 21-32
    • Schou, M.1
  • 16
    • 14544288719 scopus 로고    scopus 로고
    • Treatment options for bipolar depression
    • Bowden C.L. (2005). Treatment options for bipolar depression. J. Clin. Psychiat., 66(suppl. 1), 3-6.
    • (2005) J. Clin. Psychiat. , vol.66 , Issue.SUPPL. 1 , pp. 3-6
    • Bowden, C.L.1
  • 17
    • 0037051872 scopus 로고    scopus 로고
    • Placebo response in studies of major depression: Variable, substantial, and growing
    • Walsh B.T., Seidman S.N., Sysko R., Gould M. (2002). Placebo response in studies of major depression: Variable, substantial, and growing. JAMA, 287, 1840-1847.
    • (2002) JAMA , vol.287 , pp. 1840-1847
    • Walsh, B.T.1    Seidman, S.N.2    Sysko, R.3    Gould, M.4
  • 18
    • 4243196940 scopus 로고    scopus 로고
    • Emerging experimental therapeutics for bipolar disorder: Insights from the molecular and cellular actions of current mood stabilizers
    • Gould T.D., Quiroz J.A., Singh J., Zarate C.A., Manji H.K. (2004). Emerging experimental therapeutics for bipolar disorder: Insights from the molecular and cellular actions of current mood stabilizers. Mol. Psychiat., 9, 734-755.
    • (2004) Mol. Psychiat. , vol.9 , pp. 734-755
    • Gould, T.D.1    Quiroz, J.A.2    Singh, J.3    Zarate, C.A.4    Manji, H.K.5
  • 19
    • 4243165658 scopus 로고    scopus 로고
    • Emerging experimental therapeutics for bipolar disorder: Clues from the molecular pathophysiology
    • Quiroz J.A., Singh J., Gould T.D., Denicoff K.D., Zarate C.A., Manji H.K. (2004). Emerging experimental therapeutics for bipolar disorder: Clues from the molecular pathophysiology. Mol. Psychiat., 9, 756-776.
    • (2004) Mol. Psychiat. , vol.9 , pp. 756-776
    • Quiroz, J.A.1    Singh, J.2    Gould, T.D.3    Denicoff, K.D.4    Zarate, C.A.5    Manji, H.K.6
  • 20
    • 23744434311 scopus 로고    scopus 로고
    • GSK-3 and neurotrophic signaling: Novel targets underlying the pathophysiology and treatment of mood disorders?
    • Picchini A.M., Manji H.K., Gould T.D. (2004). GSK-3 and neurotrophic signaling: Novel targets underlying the pathophysiology and treatment of mood disorders?. Drug Disc. Today: Dis. Mech., 1, 419-428.
    • (2004) Drug Disc. Today: Dis. Mech. , vol.1 , pp. 419-428
    • Picchini, A.M.1    Manji, H.K.2    Gould, T.D.3
  • 21
    • 78651023893 scopus 로고
    • Lithium salts in the treatment of psychotic excitement
    • Cade J.F.J. (1949). Lithium salts in the treatment of psychotic excitement. Med. J. Austr., 2, 349-352.
    • (1949) Med. J. Austr. , vol.2 , pp. 349-352
    • Cade, J.F.J.1
  • 22
    • 0025860080 scopus 로고
    • Lithium treatment and prophylaxis in unipolar depression: A meta-analysis
    • Souza F.G., Goodwin G.M. (1991). Lithium treatment and prophylaxis in unipolar depression: A meta-analysis. Br. J. Psychiat., 158, 666-675.
    • (1991) Br. J. Psychiat. , vol.158 , pp. 666-675
    • Souza, F.G.1    Goodwin, G.M.2
  • 23
    • 1442289924 scopus 로고    scopus 로고
    • What is a "mood stabilizer"? An evidencebased response
    • Bauer M.S., Mitchner L. (2004). What is a "mood stabilizer"? An evidencebased response. Am. J. Psychiat., 161, 3-18.
    • (2004) Am. J. Psychiat. , vol.161 , pp. 3-18
    • Bauer, M.S.1    Mitchner, L.2
  • 24
    • 0021047672 scopus 로고
    • Lithium carbonate augmentation of antidepressant treatment: An effective prescription for treatmentrefractory depression
    • Heninger G.R., Charney D.S., Sternberg D.E. (1983). Lithium carbonate augmentation of antidepressant treatment: An effective prescription for treatmentrefractory depression. Arch. Gen. Psychiat., 40, 1335-1342.
    • (1983) Arch. Gen. Psychiat. , vol.40 , pp. 1335-1342
    • Heninger, G.R.1    Charney, D.S.2    Sternberg, D.E.3
  • 26
    • 0035663452 scopus 로고    scopus 로고
    • Arguments for the specificity of the antisuicidal effect of lithium
    • Muller-Oerlinghausen B. (2001). Arguments for the specificity of the antisuicidal effect of lithium. Eur. Arch. Psychiat. Clin. Neurosci., 251 (suppl. 2), II72-II75.
    • (2001) Eur. Arch. Psychiat. Clin. Neurosci. , vol.251 , Issue.SUPPL. 2
    • Muller-Oerlinghausen, B.1
  • 27
    • 0035010150 scopus 로고    scopus 로고
    • Treating the suicidal patient with bipolar disorder. Reducing suicide risk with lithium
    • discussion 39-43
    • Baldessarini R.J., Tondo L., Hennen J. (2001). Treating the suicidal patient with bipolar disorder. Reducing suicide risk with lithium. An. NY Acad. Sci., 932, 24-38; discussion 39-43.
    • (2001) An. NY Acad. Sci. , vol.932 , pp. 24-38
    • Baldessarini, R.J.1    Tondo, L.2    Hennen, J.3
  • 28
    • 0141834950 scopus 로고    scopus 로고
    • Suicide risk in bipolar disorder during treatment with lithium and divalproex
    • Goodwin F.K., Fireman B., Simon G.E., Hunkeler E.M., Lee J., Revicki D. (2003). Suicide risk in bipolar disorder during treatment with lithium and divalproex. JAMA, 290, 1467-1473.
    • (2003) JAMA , vol.290 , pp. 1467-1473
    • Goodwin, F.K.1    Fireman, B.2    Simon, G.E.3    Hunkeler, E.M.4    Lee, J.5    Revicki, D.6
  • 30
    • 0032947795 scopus 로고    scopus 로고
    • Anti-bipolar therapy: Mechanism of action of lithium
    • Jope R.S. (1999). Anti-bipolar therapy: Mechanism of action of lithium. Mol. Psychiat., 4, 117-128.
    • (1999) Mol. Psychiat. , vol.4 , pp. 117-128
    • Jope, R.S.1
  • 32
    • 3342900250 scopus 로고    scopus 로고
    • Bipolar disorder
    • Belmaker R.H. (2004). Bipolar disorder. N. Engl. J. Med., 351, 476-486.
    • (2004) N. Engl. J. Med. , vol.351 , pp. 476-486
    • Belmaker, R.H.1
  • 33
    • 0025316352 scopus 로고
    • Lithium research: State of the art
    • Belmaker R.H., Kofman O. (1990). Lithium research: State of the art. Biol. Psychiat., 27, 1279-1281.
    • (1990) Biol. Psychiat. , vol.27 , pp. 1279-1281
    • Belmaker, R.H.1    Kofman, O.2
  • 34
    • 0029036695 scopus 로고
    • Definition of a metal-dependent/Li(+)-inhibited phosphomonoesterase protein family based upon a conserved three-dimensional core structure
    • York J.D., Ponder J.W., Majerus P.W. (1995). Definition of a metal-dependent/Li(+)-inhibited phosphomonoesterase protein family based upon a conserved three-dimensional core structure. Proc. Natl. Acad. Sci. USA, 92, 5149-5153.
    • (1995) Proc. Natl. Acad. Sci. USA , vol.92 , pp. 5149-5153
    • York, J.D.1    Ponder, J.W.2    Majerus, P.W.3
  • 35
    • 0020044028 scopus 로고
    • Effects of lithium on the activities of phosphofructokinase and phosphoglucomutase and on glucose-1,6-diphosphate levels in rat muscles, brain and liver
    • Nordenberg J., Kaplansky M., Beery E., Klein S., Beitner R. (1982). Effects of lithium on the activities of phosphofructokinase and phosphoglucomutase and on glucose-1,6-diphosphate levels in rat muscles, brain and liver. Biochem. Pharmacol., 31, 1025-1031.
    • (1982) Biochem. Pharmacol. , vol.31 , pp. 1025-1031
    • Nordenberg, J.1    Kaplansky, M.2    Beery, E.3    Klein, S.4    Beitner, R.5
  • 36
    • 0021765663 scopus 로고
    • Enzyme-bound intermediates in the conversion of glucose 1-phosphate to glucose 6-phosphate by phosphoglucomutase: Phosphorus NMR studies
    • Rhyu G.I., Ray W.J. Jr., Markley J.L. (1984). Enzyme-bound intermediates in the conversion of glucose 1-phosphate to glucose 6-phosphate by phosphoglucomutase: Phosphorus NMR studies. Biochemistry, 23, 252-260.
    • (1984) Biochemistry , vol.23 , pp. 252-260
    • Rhyu, G.I.1    Ray Jr., W.J.2    Markley, J.L.3
  • 37
    • 0017861963 scopus 로고
    • The binding of lithium and of anionic metabolites to phosphoglucomutase
    • Ray W.J. Jr., Szymanki E.S., Ng L. (1978). The binding of lithium and of anionic metabolites to phosphoglucomutase. Biochim. Biophys. Acta, 522, 434-442.
    • (1978) Biochim. Biophys. Acta , vol.522 , pp. 434-442
    • Ray Jr., W.J.1    Szymanki, E.S.2    Ng, L.3
  • 39
    • 0029776032 scopus 로고    scopus 로고
    • A molecular mechanism for the effect of lithium on development
    • Klein P.S., Melton D.A. (1996). A molecular mechanism for the effect of lithium on development. Proc. Natl. Acad. Sci. USA, 93, 8455-8459.
    • (1996) Proc. Natl. Acad. Sci. USA , vol.93 , pp. 8455-8459
    • Klein, P.S.1    Melton, D.A.2
  • 40
    • 0030449964 scopus 로고    scopus 로고
    • Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells
    • Stambolic V., Ruel L., Woodgett J.R. (1996). Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells. Curr. Biol., 6, 1664-1668.
    • (1996) Curr. Biol. , vol.6 , pp. 1664-1668
    • Stambolic, V.1    Ruel, L.2    Woodgett, J.R.3
  • 41
    • 0008836304 scopus 로고    scopus 로고
    • Lithium, phosphatidylinositol signaling, and bipolar disorder
    • In Manji H.K., Bowden C.L., Belmaker R.H., eds., Washington, DC: American Psychiatric Press
    • Atack J.R. (2000). Lithium, phosphatidylinositol signaling, and bipolar disorder. In Manji H.K., Bowden C.L., Belmaker R.H., eds., Bipolar Medications: Mechanism of Action. Washington, DC: American Psychiatric Press, 1-30.
    • (2000) Bipolar Medications: Mechanism of Action , pp. 1-30
    • Atack, J.R.1
  • 42
    • 0026659202 scopus 로고
    • Inositol phosphate biochemistry
    • Majerus P.W. (1992). Inositol phosphate biochemistry. An. Rev. Biochem., 61, 225-250.
    • (1992) An. Rev. Biochem. , vol.61 , pp. 225-250
    • Majerus, P.W.1
  • 43
    • 0016231591 scopus 로고
    • Biosynthesis of myo-inositol in rat mammary gland. Isolation and properties of the enzymes
    • Naccarato W.F., Ray R.E., Wells W.W. (1974). Biosynthesis of myo-inositol in rat mammary gland. Isolation and properties of the enzymes. Arch. Biochem. Biophys., 164, 194-201.
    • (1974) Arch. Biochem. Biophys. , vol.164 , pp. 194-201
    • Naccarato, W.F.1    Ray, R.E.2    Wells, W.W.3
  • 44
    • 0019127799 scopus 로고
    • The effects of lithium ion and other agents on the activity of myo-inositol-1-phosphatase from bovine brain
    • Hallcher L.M., Sherman W.R. (1980). The effects of lithium ion and other agents on the activity of myo-inositol-1-phosphatase from bovine brain. J. Biol. Chem., 255, 10896-10901.
    • (1980) J. Biol. Chem. , vol.255 , pp. 10896-10901
    • Hallcher, L.M.1    Sherman, W.R.2
  • 45
    • 0024341795 scopus 로고
    • Neural and developmental actions of lithium: A unifying hypothesis
    • Berridge M.J., Downes C.P., Hanley M.R. (1989). Neural and developmental actions of lithium: A unifying hypothesis. Cell, 59, 411-419.
    • (1989) Cell , vol.59 , pp. 411-419
    • Berridge, M.J.1    Downes, C.P.2    Hanley, M.R.3
  • 46
    • 0015242494 scopus 로고
    • Reduced brain inositol in lithium-treated rats
    • Allison J.H., Stewart M.A. (1971). Reduced brain inositol in lithium-treated rats. Nat. New Biol., 233, 267-268.
    • (1971) Nat. New Biol. , vol.233 , pp. 267-268
    • Allison, J.H.1    Stewart, M.A.2
  • 47
    • 0036705074 scopus 로고    scopus 로고
    • Signaling networks in the pathophysiology and treatment of mood disorders
    • Gould T.D., Manji H.K. (2002). Signaling networks in the pathophysiology and treatment of mood disorders. J. Psychosom. Res., 53, 687-697.
    • (2002) J. Psychosom. Res. , vol.53 , pp. 687-697
    • Gould, T.D.1    Manji, H.K.2
  • 48
    • 0032744013 scopus 로고    scopus 로고
    • Temporal dissociation between lithiuminduced changes in frontal lobe myo-inositol and clinical response in manic-depressive illness
    • Moore G.J., Bebchuk J.M., Parrish J.K., Faulk M.W., Arfken C.L., Strahl-Bevacqua J., Manji H.K. (1999). Temporal dissociation between lithiuminduced changes in frontal lobe myo-inositol and clinical response in manic-depressive illness. Am. J. Psychiat., 156, 1902-1908.
    • (1999) Am. J. Psychiat. , vol.156 , pp. 1902-1908
    • Moore, G.J.1    Bebchuk, J.M.2    Parrish, J.K.3    Faulk, M.W.4    Arfken, C.L.5    Strahl-Bevacqua, J.6    Manji, H.K.7
  • 49
    • 0033570745 scopus 로고    scopus 로고
    • Ziskind-Somerfeld Research Award. Protein kinase C signaling in the brain: Molecular transduction of mood stabilization in the treatment of manic-depressive illness
    • Manji H.K., Lenox R.H. (1999). Ziskind-Somerfeld Research Award. Protein kinase C signaling in the brain: Molecular transduction of mood stabilization in the treatment of manic-depressive illness. Biol. Psychiat., 46, 1328-1351.
    • (1999) Biol. Psychiat. , vol.46 , pp. 1328-1351
    • Manji, H.K.1    Lenox, R.H.2
  • 50
    • 0030898340 scopus 로고    scopus 로고
    • Inositol monophosphatase inhibitors-lithium mimetics? Med
    • Atack J.R. (1997). Inositol monophosphatase inhibitors-lithium mimetics? Med. Res. Rev., 17, 215-224.
    • (1997) Res. Rev. , vol.17 , pp. 215-224
    • Atack, J.R.1
  • 51
    • 0027458537 scopus 로고
    • In vitro and in vivo inhibition of inositol monophosphatase by the bisphosphonate L-690,330
    • Atack J.R., Cook S.M., Watt A.P., Fletcher S.R., Ragan C.I. (1993). In vitro and in vivo inhibition of inositol monophosphatase by the bisphosphonate L-690,330. J. Neurochem., 60, 652-658.
    • (1993) J. Neurochem. , vol.60 , pp. 652-658
    • Atack, J.R.1    Cook, S.M.2    Watt, A.P.3    Fletcher, S.R.4    Ragan, C.I.5
  • 52
    • 0028339390 scopus 로고
    • Effects of L-690,488, a prodrug of the bisphosphonate inositol monophosphatase inhibitor L-690,330, on phosphatidylinositol cycle markers
    • Atack J.R., Prior A.M., Fletcher S.R., Quirk K., McKernan R., Ragan C.I. (1994). Effects of L-690,488, a prodrug of the bisphosphonate inositol monophosphatase inhibitor L-690,330, on phosphatidylinositol cycle markers. J. Pharmacol. Exp. Ther., 270, 70-76.
    • (1994) J. Pharmacol. Exp. Ther. , vol.270 , pp. 70-76
    • Atack, J.R.1    Prior, A.M.2    Fletcher, S.R.3    Quirk, K.4    McKernan, R.5    Ragan, C.I.6
  • 54
    • 0026493674 scopus 로고
    • Structure of inositol monophosphatase, the putative target of lithium therapy
    • Bone R., Springer J.P., Atack J.R. (1992). Structure of inositol monophosphatase, the putative target of lithium therapy. Proc. Natl. Acad. Sci. USA, 89, 10031-10035.
    • (1992) Proc. Natl. Acad. Sci. USA , vol.89 , pp. 10031-10035
    • Bone, R.1    Springer, J.P.2    Atack, J.R.3
  • 56
    • 0034859101 scopus 로고    scopus 로고
    • The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling
    • Grimes C.A., Jope R.S. (2001). The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling. Prog. Neurobiol., 65, 391-426.
    • (2001) Prog. Neurobiol. , vol.65 , pp. 391-426
    • Grimes, C.A.1    Jope, R.S.2
  • 57
    • 0035909112 scopus 로고    scopus 로고
    • Judging a protein by more than its name: GSK-3
    • Woodgett J.R. (2001). Judging a protein by more than its name: GSK-3. Sci. STKE, RE12.
    • (2001) Sci. STKE , vol.RE12
    • Woodgett, J.R.1
  • 58
    • 0035477020 scopus 로고    scopus 로고
    • GSK-3 takes centre stage more than 20 years after its discovery
    • Frame S., Cohen P. (2001). GSK-3 takes centre stage more than 20 years after its discovery. Biochem. J., 359, 1-16.
    • (2001) Biochem. J. , vol.359 , pp. 1-16
    • Frame, S.1    Cohen, P.2
  • 59
    • 8444251784 scopus 로고    scopus 로고
    • The Wnt signaling pathway in development and disease
    • Logan C.Y., Nusse R. (2004). The Wnt signaling pathway in development and disease. An. Rev. Cell. Dev. Biol., 20, 781-810.
    • (2004) An. Rev. Cell. Dev. Biol. , vol.20 , pp. 781-810
    • Logan, C.Y.1    Nusse, R.2
  • 60
    • 0141740215 scopus 로고    scopus 로고
    • Challenges and opportunities with glycogen synthase kinase-3 inhibitors for insulin resistance and type 2 diabetes treatment
    • Eldar-Finkelman H., Ilouz R. (2003). Challenges and opportunities with glycogen synthase kinase-3 inhibitors for insulin resistance and type 2 diabetes treatment. Expert Opin. Investig. Drugs, 12, 1511-1519.
    • (2003) Expert Opin. Investig. Drugs , vol.12 , pp. 1511-1519
    • Eldar-Finkelman, H.1    Ilouz, R.2
  • 61
    • 4844230621 scopus 로고    scopus 로고
    • The Frizzled family: Receptors for multiple signal transduction pathways
    • Huang H.C., Klein P.S. (2004). The Frizzled family: Receptors for multiple signal transduction pathways. Genome Biol., 5, 234.
    • (2004) Genome Biol. , vol.5 , pp. 234
    • Huang, H.C.1    Klein, P.S.2
  • 62
    • 0442276554 scopus 로고    scopus 로고
    • The glamour and gloom of glycogen synthase kinase-3
    • Jope R.S., Johnson G.V. (2004). The glamour and gloom of glycogen synthase kinase-3. Trends Biochem. Sci., 29, 95-102.
    • (2004) Trends Biochem. Sci. , vol.29 , pp. 95-102
    • Jope, R.S.1    Johnson, G.V.2
  • 63
    • 0036788036 scopus 로고    scopus 로고
    • The Wnt signaling pathway in bipolar disorder
    • Gould T.D., Manji H.K. (2002). The Wnt signaling pathway in bipolar disorder. Neuroscientist, 8, 497-511.
    • (2002) Neuroscientist , vol.8 , pp. 497-511
    • Gould, T.D.1    Manji, H.K.2
  • 64
    • 0034805180 scopus 로고    scopus 로고
    • Lithium inhibits glycogen synthase kinase-3 by competition for magnesium
    • Ryves W.J., Harwood A.J. (2001). Lithium inhibits glycogen synthase kinase-3 by competition for magnesium. Biochem. Biophys. Res. Commun., 280, 720-725.
    • (2001) Biochem. Biophys. Res. Commun. , vol.280 , pp. 720-725
    • Ryves, W.J.1    Harwood, A.J.2
  • 65
    • 0036810240 scopus 로고    scopus 로고
    • Lithium and valproic acid: Parallels and contrasts in diverse signaling contexts
    • Gurvich N., Klein P.S. (2002). Lithium and valproic acid: Parallels and contrasts in diverse signaling contexts. Pharmacol. Ther., 96, 45-66.
    • (2002) Pharmacol. Ther. , vol.96 , pp. 45-66
    • Gurvich, N.1    Klein, P.S.2
  • 66
    • 0036295233 scopus 로고    scopus 로고
    • Glycogen synthase kinase-3 inhibition by lithium and beryllium suggests the presence of two magnesium binding sites
    • Ryves W.J., Dajani R., Pearl L., Harwood A.J. (2002). Glycogen synthase kinase-3 inhibition by lithium and beryllium suggests the presence of two magnesium binding sites. Biochem. Biophys. Res. Commun., 290, 967-972.
    • (2002) Biochem. Biophys. Res. Commun. , vol.290 , pp. 967-972
    • Ryves, W.J.1    Dajani, R.2    Pearl, L.3    Harwood, A.J.4
  • 67
    • 0036302005 scopus 로고    scopus 로고
    • Inhibition of glycogen synthase kinase-3beta by bivalent zinc ions: Insight into the insulin-mimetic action of zinc
    • Ilouz R., Kaidanovich O., Gurwitz D., Eldar-Finkelman H. (2002). Inhibition of glycogen synthase kinase-3beta by bivalent zinc ions: Insight into the insulin-mimetic action of zinc. Biochem. Biophys. Res. Commun., 295, 102-106.
    • (2002) Biochem. Biophys. Res. Commun. , vol.295 , pp. 102-106
    • Ilouz, R.1    Kaidanovich, O.2    Gurwitz, D.3    Eldar-Finkelman, H.4
  • 68
    • 0034751373 scopus 로고    scopus 로고
    • Hypermagnesemia does not increase brain intracellular magnesium in newborn swine
    • Gee J.B. 2nd Corbett R.J., Perlman J.M., Laptook A.R. (2001). Hypermagnesemia does not increase brain intracellular magnesium in newborn swine. Pediatr. Neurol., 25, 304-308.
    • (2001) Pediatr. Neurol. , vol.25 , pp. 304-308
    • Gee II, J.B.1    Corbett, R.J.2    Perlman, J.M.3    Laptook, A.R.4
  • 69
    • 0033561802 scopus 로고    scopus 로고
    • Intracellular Mg2+ surge follows Ca2+ increase during depolarization in cultured neurons
    • Gotoh H., Kajikawa M., Kato H., Suto K. (1999). Intracellular Mg2+ surge follows Ca2+ increase during depolarization in cultured neurons. Brain Res., 828, 163-168.
    • (1999) Brain Res. , vol.828 , pp. 163-168
    • Gotoh, H.1    Kajikawa, M.2    Kato, H.3    Suto, K.4
  • 70
    • 0035875483 scopus 로고    scopus 로고
    • Free intracellular Mg(2+) concentration and inhibition of NMDA responses in cultured rat neurons
    • Li-Smerin Y., Levitan E.S., Johnson J.W. (2001). Free intracellular Mg(2+) concentration and inhibition of NMDA responses in cultured rat neurons. J. Physiol., 533, 729-743.
    • (2001) J. Physiol. , vol.533 , pp. 729-743
    • Li-Smerin, Y.1    Levitan, E.S.2    Johnson, J.W.3
  • 71
    • 0027452219 scopus 로고
    • Glutamate-induced increases in intracellular free Mg2+ in cultured cortical neurons
    • Brocard J.B., Rajdev S., Reynolds I.J. (1993). Glutamate-induced increases in intracellular free Mg2+ in cultured cortical neurons. Neuron, 11, 751-757.
    • (1993) Neuron , vol.11 , pp. 751-757
    • Brocard, J.B.1    Rajdev, S.2    Reynolds, I.J.3
  • 73
    • 0033587742 scopus 로고    scopus 로고
    • Lithium activates the serine/threonine kinase Akt-1 and suppresses glutamate-induced inhibition of Akt-1 activity in neurons
    • Chalecka-Franaszek E., Chuang D.M. (1999). Lithium activates the serine/threonine kinase Akt-1 and suppresses glutamate-induced inhibition of Akt-1 activity in neurons. Proc. Natl. Acad. Sci. USA, 96, 8745-8750.
    • (1999) Proc. Natl. Acad. Sci. USA , vol.96 , pp. 8745-8750
    • Chalecka-Franaszek, E.1    Chuang, D.M.2
  • 74
    • 0036909443 scopus 로고    scopus 로고
    • Regulation of Akt and glycogen synthase kinase-3beta phosphorylation by sodium valproate and lithium
    • De Sarno P., Li X., Jope R.S. (2002). Regulation of Akt and glycogen synthase kinase-3beta phosphorylation by sodium valproate and lithium. Neuropharmacology, 43, 1158-1164.
    • (2002) Neuropharmacology , vol.43 , pp. 1158-1164
    • De Sarno, P.1    Li, X.2    Jope, R.S.3
  • 75
    • 0042379932 scopus 로고    scopus 로고
    • Lithium and GSK-3: One inhibitor, two inhibitory actions, multiple outcomes
    • Jope R.S. (2003). Lithium and GSK-3: One inhibitor, two inhibitory actions, multiple outcomes. Trends. Pharmacol. Sci., 24, 441-443.
    • (2003) Trends. Pharmacol. Sci. , vol.24 , pp. 441-443
    • Jope, R.S.1
  • 76
    • 0042357237 scopus 로고    scopus 로고
    • Inhibitory phosphorylation of glycogen synthase kinase-3 (GSK-3) in response to lithium: Evidence for autoregulation of GSK-3
    • Zhang F., Phiel C.J., Spece L., Gurvich N., Klein P.S. (2003). Inhibitory phosphorylation of glycogen synthase kinase-3 (GSK-3) in response to lithium: Evidence for autoregulation of GSK-3. J. Biol. Chem., 278, 33067-33077.
    • (2003) J. Biol. Chem. , vol.278 , pp. 33067-33077
    • Zhang, F.1    Phiel, C.J.2    Spece, L.3    Gurvich, N.4    Klein, P.S.5
  • 77
    • 17044423920 scopus 로고    scopus 로고
    • Lithium-mediated phosphorylation of glycogen synthase kinase-3b involves PI3 kinase-dependent activation of protein kinase C-alpha
    • Kirshenboim N., Plotkin B., Shlomo S.B., Kaidanovich-Beilin O., Eldar-Finkelman H. (2004). Lithium-mediated phosphorylation of glycogen synthase kinase-3b involves PI3 kinase-dependent activation of protein kinase C-alpha. J. Mol. Neurosci., 24, 237-246.
    • (2004) J. Mol. Neurosci. , vol.24 , pp. 237-246
    • Kirshenboim, N.1    Plotkin, B.2    Shlomo, S.B.3    Kaidanovich-Beilin, O.4    Eldar-Finkelman, H.5
  • 78
    • 0031567583 scopus 로고    scopus 로고
    • Lithium inhibits Alzheimer's disease-like Tau protein phosphorylation in neurons
    • Munoz-Montano J.R., Moreno F.J., Avila J., Díaz-Nido J. (1997). Lithium inhibits Alzheimer's disease-like Tau protein phosphorylation in neurons. FEBS. Lett., 411, 183-188.
    • (1997) FEBS. Lett. , vol.411 , pp. 183-188
    • Munoz-Montano, J.R.1    Moreno, F.J.2    Avila, J.3    Díaz-Nido, J.4
  • 80
    • 3342955475 scopus 로고    scopus 로고
    • Glycogen synthase kinase-3beta haploinsufficiency mimics the behavioral and molecular effects of lithium
    • O'Brien W.T., Harper A.D., Jove F., Woodgett J.R., Maretto S., Piccolo S., Klein P.S. (2004). Glycogen synthase kinase-3beta haploinsufficiency mimics the behavioral and molecular effects of lithium. J. Neurosci., 24, 6791-6798.
    • (2004) J. Neurosci. , vol.24 , pp. 6791-6798
    • O'Brien, W.T.1    Harper, A.D.2    Jove, F.3    Woodgett, J.R.4    Maretto, S.5    Piccolo, S.6    Klein, P.S.7
  • 81
    • 0346688565 scopus 로고    scopus 로고
    • In vivo evidence in the brain for lithium inhibition of glycogen synthase kinase-3
    • Gould T.D., Chen G., Manji H.K. (2004). In vivo evidence in the brain for lithium inhibition of glycogen synthase kinase-3. Neuropsychopharmacology, 29, 32-38.
    • (2004) Neuropsychopharmacology , vol.29 , pp. 32-38
    • Gould, T.D.1    Chen, G.2    Manji, H.K.3
  • 82
    • 84889293233 scopus 로고    scopus 로고
    • Targeting glycogen synthase kinase-3 in the CNS: implications for the development of new treatments for mood disorders
    • in press
    • Gould T.D., Picchini A.M., Einat H., Manji H.K. (in press). Targeting glycogen synthase kinase-3 in the CNS: implications for the development of new treatments for mood disorders. Curr. Drug Targets.
    • Curr. Drug Targets
    • Gould, T.D.1    Picchini, A.M.2    Einat, H.3    Manji, H.K.4
  • 84
    • 0023605089 scopus 로고
    • Use of valpromide in psychiatric therapeutics
    • Lambert P.A., Venaud G. (1987). Use of valpromide in psychiatric therapeutics. Encephale, 13, 367-373.
    • (1987) Encephale , vol.13 , pp. 367-373
    • Lambert, P.A.1    Venaud, G.2
  • 87
    • 0034781283 scopus 로고    scopus 로고
    • Brief history of the development of valproate in bipolar disorders
    • Lemperiere T. (2001). Brief history of the development of valproate in bipolar disorders. Encephale, 27, 365-372.
    • (2001) Encephale , vol.27 , pp. 365-372
    • Lemperiere, T.1
  • 88
    • 0002554671 scopus 로고
    • Comparative study of valpromide versus lithium in the treatment of affective disorders
    • Lambert P.A., Venaud G. (1992). Comparative study of valpromide versus lithium in the treatment of affective disorders. Nervure, 5, 57-65.
    • (1992) Nervure , vol.5 , pp. 57-65
    • Lambert, P.A.1    Venaud, G.2
  • 90
    • 0033014180 scopus 로고    scopus 로고
    • The mood-stabilizing agent valproate inhibits the activity of glycogen synthase kinase-3
    • Chen G., Huang L.D., Jiang Y.M., Manji H.K. (1999). The mood-stabilizing agent valproate inhibits the activity of glycogen synthase kinase-3. J. Neurochem, 72, 1327-1330.
    • (1999) J. Neurochem , vol.72 , pp. 1327-1330
    • Chen, G.1    Huang, L.D.2    Jiang, Y.M.3    Manji, H.K.4
  • 91
    • 0034806590 scopus 로고    scopus 로고
    • CREB DNA binding activity is inhibited by glycogen synthase kinase-3beta and facilitated by lithium
    • Grimes A.C., Jope R.S. (2001). CREB DNA binding activity is inhibited by glycogen synthase kinase-3beta and facilitated by lithium. J. Neurochem, 78, 1219-1232.
    • (2001) J. Neurochem , vol.78 , pp. 1219-1232
    • Grimes, A.C.1    Jope, R.S.2
  • 92
    • 5144226319 scopus 로고    scopus 로고
    • Examining the correlations between GSK-3 inhibitory properties and anti-convulsant efficacy of valproate and valproate-related compounds
    • Werstuck G.H., Kim A.J., Brenstrum T., Ohnmacht S.A., Panna E., Capretta A. (2004). Examining the correlations between GSK-3 inhibitory properties and anti-convulsant efficacy of valproate and valproate-related compounds. Bioorg. Med. Chem. Lett., 14, 5465-5467.
    • (2004) Bioorg. Med. Chem. Lett. , vol.14 , pp. 5465-5467
    • Werstuck, G.H.1    Kim, A.J.2    Brenstrum, T.3    Ohnmacht, S.A.4    Panna, E.5    Capretta, A.6
  • 93
    • 14044261099 scopus 로고    scopus 로고
    • Valproate protects cells from ER stress-induced lipid accumulation and apoptosis by inhibiting glycogen synthase kinase-3
    • Kim A.J., Shi Y., Austin R.C., Werstuck G.H. (2005). Valproate protects cells from ER stress-induced lipid accumulation and apoptosis by inhibiting glycogen synthase kinase-3. J. Cell. Sci., 118, 89-99.
    • (2005) J. Cell. Sci. , vol.118 , pp. 89-99
    • Kim, A.J.1    Shi, Y.2    Austin, R.C.3    Werstuck, G.H.4
  • 94
    • 0035965343 scopus 로고    scopus 로고
    • Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen
    • Phiel C.J., Zhang F., Huang E.Y., Guenther M.G., Lazar M.A., Klein P.S. (2001). Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. J. Biol. Chem., 276, 36734-36741.
    • (2001) J. Biol. Chem. , vol.276 , pp. 36734-36741
    • Phiel, C.J.1    Zhang, F.2    Huang, E.Y.3    Guenther, M.G.4    Lazar, M.A.5    Klein, P.S.6
  • 95
    • 0037118050 scopus 로고    scopus 로고
    • A common mechanism of action for three mood-stabilizing drugs
    • Williams R.S., Cheng L., Mudge A.W., Harwood A.J. (2002). A common mechanism of action for three mood-stabilizing drugs. Nature, 417, 292-295.
    • (2002) Nature , vol.417 , pp. 292-295
    • Williams, R.S.1    Cheng, L.2    Mudge, A.W.3    Harwood, A.J.4
  • 96
    • 20944435414 scopus 로고    scopus 로고
    • Effects of valproic acid derivatives on inositol trisphosphate depletion, teratogenicity, GSK-3{beta} inhibition and viral replication-A screening approach for new bipolar disorder drugs based on the valproic acid core structure
    • Williams R.S., Eickholt B.J., Towers G., Ryves W.J., Eikel D., Adley K., Ylinen L., Chadborn N., Harwood A., Nau H. (2005). Effects of valproic acid derivatives on inositol trisphosphate depletion, teratogenicity, GSK-3{beta} inhibition and viral replication-A screening approach for new bipolar disorder drugs based on the valproic acid core structure. Mol. Pharmacol., 67, 1426-1433.
    • (2005) Mol. Pharmacol. , vol.67 , pp. 1426-1433
    • Williams, R.S.1    Eickholt, B.J.2    Towers, G.3    Ryves, W.J.4    Eikel, D.5    Adley, K.6    Ylinen, L.7    Chadborn, N.8    Harwood, A.9    Nau, H.10
  • 97
    • 20344363201 scopus 로고    scopus 로고
    • GSK-3 activity in neocortical cells is inhibited by lithium but not carbamazepine or valproic acid
    • Jonathan Ryves W., Dalton E.C., Harwood A.J., Williams R.S. (2005). GSK-3 activity in neocortical cells is inhibited by lithium but not carbamazepine or valproic acid. Bipolar Disord., 7, 260-265.
    • (2005) Bipolar Disord. , vol.7 , pp. 260-265
    • Jonathan Ryves, W.1    Dalton, E.C.2    Harwood, A.J.3    Williams, R.S.4
  • 99
    • 13244257028 scopus 로고    scopus 로고
    • Hypoxia activates glycogen synthase kinase-3 in mouse brain in vivo: protection by mood stabilizers and imipramine
    • Roh M.S., Eom T.Y., Zmijewska A.A., De Sarno P., Roth K.A., Jope R.S. (2005). Hypoxia activates glycogen synthase kinase-3 in mouse brain in vivo: protection by mood stabilizers and imipramine. Biol. Psychiat., 57, 278-286.
    • (2005) Biol. Psychiat. , vol.57 , pp. 278-286
    • Roh, M.S.1    Eom, T.Y.2    Zmijewska, A.A.3    De Sarno, P.4    Roth, K.A.5    Jope, R.S.6
  • 100
    • 0036103182 scopus 로고    scopus 로고
    • Glycogen synthase kinase 3-beta, mood stabilizers, and neuroprotection
    • Li X., Bijur G.N., Jope R.S. (2002). Glycogen synthase kinase 3-beta, mood stabilizers, and neuroprotection. Bipolar Disord., 4, 137-144.
    • (2002) Bipolar Disord. , vol.4 , pp. 137-144
    • Li, X.1    Bijur, G.N.2    Jope, R.S.3
  • 101
    • 3242761438 scopus 로고    scopus 로고
    • In vivo regulation of glycogen synthase kinase-3beta (GSK3beta) by serotonergic activity in mouse brain
    • Li X., Zhu W., Roh M.S., Friedman A.B., Rosborough K., Jope R.S. (2004). In vivo regulation of glycogen synthase kinase-3beta (GSK3beta) by serotonergic activity in mouse brain. Neuropsychopharmacology, 29, 1426-1431.
    • (2004) Neuropsychopharmacology , vol.29 , pp. 1426-1431
    • Li, X.1    Zhu, W.2    Roh, M.S.3    Friedman, A.B.4    Rosborough, K.5    Jope, R.S.6
  • 102
    • 0028047366 scopus 로고
    • Electroconvulsive therapy of acute manic episodes: a review of 50 years' experience
    • Mukherjee S., Sackeim H.A., Schnur D.B. (1994). Electroconvulsive therapy of acute manic episodes: a review of 50 years' experience. Am. J. Psychiat., 151, 169-176.
    • (1994) Am. J. Psychiat. , vol.151 , pp. 169-176
    • Mukherjee, S.1    Sackeim, H.A.2    Schnur, D.B.3
  • 105
    • 0242391951 scopus 로고    scopus 로고
    • Chronic electroconvulsive seizure up-regulates beta-catenin expression in rat hippocampus: Role in adult neurogenesis
    • Madsen T.M., Newton S.S., Eaton M.E., Russell D.S., Duman R.S. (2003). Chronic electroconvulsive seizure up-regulates beta-catenin expression in rat hippocampus: Role in adult neurogenesis. Biol. Psychiat., 54, 1006-1014.
    • (2003) Biol. Psychiat. , vol.54 , pp. 1006-1014
    • Madsen, T.M.1    Newton, S.S.2    Eaton, M.E.3    Russell, D.S.4    Duman, R.S.5
  • 106
    • 0034671366 scopus 로고    scopus 로고
    • Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus
    • Malberg J.E., Eisch A.J., Nestler E.J., Duman R.S. (2000). Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J. Neurosci., 20, 9104-9110.
    • (2000) J. Neurosci. , vol.20 , pp. 9104-9110
    • Malberg, J.E.1    Eisch, A.J.2    Nestler, E.J.3    Duman, R.S.4
  • 107
    • 1342308071 scopus 로고    scopus 로고
    • The effects of clozapine on the GSK-3-mediated signaling pathway
    • Kang U.G., Seo M.S., Roh M.S., Kim Y., Yoon S.C., Kim Y.S. (2004). The effects of clozapine on the GSK-3-mediated signaling pathway. FEBS Lett., 560, 115-119.
    • (2004) FEBS Lett. , vol.560 , pp. 115-119
    • Kang, U.G.1    Seo, M.S.2    Roh, M.S.3    Kim, Y.4    Yoon, S.C.5    Kim, Y.S.6
  • 108
    • 0842310838 scopus 로고    scopus 로고
    • Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia
    • Emamian E.S., Hall D., Birnbaum M.J., Karayiorgou M., Gogos J.A. (2004). Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia. Nat. Genet., 36, 131-137.
    • (2004) Nat. Genet. , vol.36 , pp. 131-137
    • Emamian, E.S.1    Hall, D.2    Birnbaum, M.J.3    Karayiorgou, M.4    Gogos, J.A.5
  • 109
    • 14644389398 scopus 로고    scopus 로고
    • Antipsychotics alter the protein expression levels of beta-catenin and GSK-3 in the rat medial prefrontal cortex and striatum
    • Alimohamad H., Rajakumar N., Seah Y.H., Rushlow W. (2005). Antipsychotics alter the protein expression levels of beta-catenin and GSK-3 in the rat medial prefrontal cortex and striatum. Biol. Psychiat., 57, 533-542.
    • (2005) Biol. Psychiat. , vol.57 , pp. 533-542
    • Alimohamad, H.1    Rajakumar, N.2    Seah, Y.H.3    Rushlow, W.4
  • 110
    • 0042623603 scopus 로고    scopus 로고
    • The role of estrogen in mood disorders in women
    • Payne J.L. (2003). The role of estrogen in mood disorders in women. Int. Rev. Psychiat., 15, 280-290.
    • (2003) Int. Rev. Psychiat. , vol.15 , pp. 280-290
    • Payne, J.L.1
  • 111
    • 0037573216 scopus 로고    scopus 로고
    • Endocrine factors in the etiology of postpartum depression
    • Bloch M., Daly R.C., Rubinow D.R. (2003). Endocrine factors in the etiology of postpartum depression. Compr. Psychiat., 44, 234-246.
    • (2003) Compr. Psychiat. , vol.44 , pp. 234-246
    • Bloch, M.1    Daly, R.C.2    Rubinow, D.R.3
  • 112
    • 0035040148 scopus 로고    scopus 로고
    • Neurotrophic and neuroprotective actions of estrogens and their therapeutic implications
    • Lee S.J., McEwen B.S. (2001). Neurotrophic and neuroprotective actions of estrogens and their therapeutic implications. An. Rev. Pharmacol. Toxicol., 41, 569-591.
    • (2001) An. Rev. Pharmacol. Toxicol. , vol.41 , pp. 569-591
    • Lee, S.J.1    McEwen, B.S.2
  • 113
    • 0035662941 scopus 로고    scopus 로고
    • Estradiol, in the CNS, targets several physiologically relevant membrane-associated proteins
    • Ramirez V.D., Kipp J.L., Joe I. (2001). Estradiol, in the CNS, targets several physiologically relevant membrane-associated proteins. Brain. Res. Rev., 37, 141-152.
    • (2001) Brain. Res. Rev. , vol.37 , pp. 141-152
    • Ramirez, V.D.1    Kipp, J.L.2    Joe, I.3
  • 114
    • 1642375658 scopus 로고    scopus 로고
    • Estradiol inhibits GSK-3 and regulates interaction of estrogen receptors, GSK-3, and beta-catenin in the hippocampus
    • Cardona-Gomez P., Perez M., Avila J., Garcia-Segura L.M., Wandosell F. (2004). Estradiol inhibits GSK-3 and regulates interaction of estrogen receptors, GSK-3, and beta-catenin in the hippocampus. Mol. Cell. Neurosci., 25, 363-373.
    • (2004) Mol. Cell. Neurosci. , vol.25 , pp. 363-373
    • Cardona-Gomez, P.1    Perez, M.2    Avila, J.3    Garcia-Segura, L.M.4    Wandosell, F.5
  • 117
    • 84889297082 scopus 로고    scopus 로고
    • Glycogen synthase kinase-3 interacts with and phosphorylates estrogen receptor-alpha and is involved in the regulation of receptor activity
    • in press
    • Medunjanin S., Hermani A., De Servi B., Grisouard J., Rincke G., Mayer D. (in press). Glycogen synthase kinase-3 interacts with and phosphorylates estrogen receptor-alpha and is involved in the regulation of receptor activity. J. Biol. Chem.
    • J. Biol. Chem
    • Medunjanin, S.1    Hermani, A.2    De Servi, B.3    Grisouard, J.4    Rincke, G.5    Mayer, D.6
  • 119
    • 0030875687 scopus 로고    scopus 로고
    • Chromosomal mapping and mutational analysis of the coding region of the glycogen synthase kinase-3alpha and beta isoforms in patients with NIDDM
    • Hansen L., Arden K.C., Rasmussen S.B., Viars C.S., Vestergaard H., Hansen T., Moller A.M., Woodgett J.R., Pedersen O. (1997). Chromosomal mapping and mutational analysis of the coding region of the glycogen synthase kinase-3alpha and beta isoforms in patients with NIDDM. Diabetologia, 40, 940-946.
    • (1997) Diabetologia , vol.40 , pp. 940-946
    • Hansen, L.1    Arden, K.C.2    Rasmussen, S.B.3    Viars, C.S.4    Vestergaard, H.5    Hansen, T.6    Moller, A.M.7    Woodgett, J.R.8    Pedersen, O.9
  • 120
    • 0036382831 scopus 로고    scopus 로고
    • A genome screen of 13 bipolar affective disorder pedigrees provides evidence for susceptibility loci on chromosome 3 as well as chromosomes 9, 13 and 19
    • Badenhop R.F., Moses M.J., Scimone A., Mitchell P.B., Ewen-White K.R., Rosso A., Donald J.A., Adams L.J., Schofield P.R. (2002). A genome screen of 13 bipolar affective disorder pedigrees provides evidence for susceptibility loci on chromosome 3 as well as chromosomes 9, 13 and 19. Mol. Psychiat., 7, 851-859.
    • (2002) Mol. Psychiat. , vol.7 , pp. 851-859
    • Badenhop, R.F.1    Moses, M.J.2    Scimone, A.3    Mitchell, P.B.4    Ewen-White, K.R.5    Rosso, A.6    Donald, J.A.7    Adams, L.J.8    Schofield, P.R.9
  • 121
    • 0028877463 scopus 로고
    • Genetic dissection of complex traits: Guidelines for interpreting and reporting linkage results
    • Lander E., Kruglyak L. (1995). Genetic dissection of complex traits: Guidelines for interpreting and reporting linkage results. Nat. Genet., 11, 241-247.
    • (1995) Nat. Genet. , vol.11 , pp. 241-247
    • Lander, E.1    Kruglyak, L.2
  • 122
    • 0035062230 scopus 로고    scopus 로고
    • Identification of sequence variants and analysis of the role of the glycogen synthase kinase 3 beta gene and promoter in late onset Alzheimer's disease
    • Russ C., Lovestone S., Powell J.F. (2001). Identification of sequence variants and analysis of the role of the glycogen synthase kinase 3 beta gene and promoter in late onset Alzheimer's disease. Mol. Psychiat., 6, 320-324.
    • (2001) Mol. Psychiat. , vol.6 , pp. 320-324
    • Russ, C.1    Lovestone, S.2    Powell, J.F.3
  • 123
    • 20544472054 scopus 로고    scopus 로고
    • Glycogen synthase kinase (GSK) gene promoter polymorphism: a TDT and haplotype approach in mood disorders
    • Tubazio V., Benedetti F., Serretti A., Plioa C., Pirovano A., Smeraldi E. (2004). Glycogen synthase kinase (GSK) gene promoter polymorphism: a TDT and haplotype approach in mood disorders. Am. J. Med. Genet., 130B, P1.24.
    • (2004) Am. J. Med. Genet. , vol.130 B
    • Tubazio, V.1    Benedetti, F.2    Serretti, A.3    Plioa, C.4    Pirovano, A.5    Smeraldi, E.6
  • 124
    • 0038823525 scopus 로고    scopus 로고
    • The endophenotype concept in psychiatry: Etymology and strategic intentions
    • Gottesman I.I., Gould T.D. (2003). The endophenotype concept in psychiatry: Etymology and strategic intentions. Am. J. Psychiat., 160, 636-645.
    • (2003) Am. J. Psychiat. , vol.160 , pp. 636-645
    • Gottesman, I.I.1    Gould, T.D.2
  • 125
    • 4444350746 scopus 로고    scopus 로고
    • A glycogen synthase kinase 3-beta promoter gene single nucleotide polymorphism is associated with age at onset and response to total sleep deprivation in bipolar depression
    • Benedetti F., Serretti A., Colombo C., Lorenzi C., Tubazio V., Smeraldi E. (2004). A glycogen synthase kinase 3-beta promoter gene single nucleotide polymorphism is associated with age at onset and response to total sleep deprivation in bipolar depression. Neurosci. Lett., 368, 123-126.
    • (2004) Neurosci. Lett. , vol.368 , pp. 123-126
    • Benedetti, F.1    Serretti, A.2    Colombo, C.3    Lorenzi, C.4    Tubazio, V.5    Smeraldi, E.6
  • 126
    • 13444269371 scopus 로고    scopus 로고
    • Long-term response to lithium salts in bipolar illness is influenced by the glycogen synthase kinase 3-beta-50 T/C SNP
    • Benedetti F., Serretti A., Pontiggia A., Bernasconi A., Lorenzi C., Colombo C., Smeraldi E. (2005). Long-term response to lithium salts in bipolar illness is influenced by the glycogen synthase kinase 3-beta-50 T/C SNP. Neurosci. Lett., 376, 51-55.
    • (2005) Neurosci. Lett. , vol.376 , pp. 51-55
    • Benedetti, F.1    Serretti, A.2    Pontiggia, A.3    Bernasconi, A.4    Lorenzi, C.5    Colombo, C.6    Smeraldi, E.7
  • 127
    • 0346023025 scopus 로고    scopus 로고
    • A single nucleotide polymorphism in glycogen synthase kinase 3-beta promoter gene influences onset of illness in patients affected by bipolar disorder
    • Benedetti F., Bernasconi A., Lorenzi C., Pontiggia A., Serretti A., Colombo C., Smeraldi E. (2004). A single nucleotide polymorphism in glycogen synthase kinase 3-beta promoter gene influences onset of illness in patients affected by bipolar disorder. Neurosci. Lett., 355, 37-40.
    • (2004) Neurosci. Lett. , vol.355 , pp. 37-40
    • Benedetti, F.1    Bernasconi, A.2    Lorenzi, C.3    Pontiggia, A.4    Serretti, A.5    Colombo, C.6    Smeraldi, E.7
  • 129
    • 0038285713 scopus 로고    scopus 로고
    • Effect of the new antiepileptic drug levetiracetam in an animal model of mania
    • Lamberty Y., Margineanu D.G., Klitgaard H. (2001). Effect of the new antiepileptic drug levetiracetam in an animal model of mania. Epilepsy Behav., 2, 454-459.
    • (2001) Epilepsy Behav. , vol.2 , pp. 454-459
    • Lamberty, Y.1    Margineanu, D.G.2    Klitgaard, H.3
  • 131
    • 0016777583 scopus 로고
    • Attenuation of the euphoriant and activating effects of d-and l-amphetamine by lithium carbonate treatment
    • Van Kammen D.P., Murphy D.L. (1975). Attenuation of the euphoriant and activating effects of d-and l-amphetamine by lithium carbonate treatment. Psychopharmacologia, 44, 215-224.
    • (1975) Psychopharmacologia , vol.44 , pp. 215-224
    • Van Kammen, D.P.1    Murphy, D.L.2
  • 134
    • 10644255687 scopus 로고    scopus 로고
    • AR-A014418, a selective GSK-3 inhibitor, produces antidepressant-like effects in the forced swim test
    • Gould T.D., Einat H., Bhat R., Manji H.K. (2004). AR-A014418, a selective GSK-3 inhibitor, produces antidepressant-like effects in the forced swim test. Int. J. Neuropsychopharmacol.1-4.
    • (2004) Int. J. Neuropsychopharmacol , pp. 1-4
    • Gould, T.D.1    Einat, H.2    Bhat, R.3    Manji, H.K.4
  • 135
    • 0017618768 scopus 로고
    • Depression: A new animal model sensitive to antidepressant treatments
    • Porsolt R.D., Le Pichon M., Jalfre M. (1977). Depression: A new animal model sensitive to antidepressant treatments. Nature, 266, 730-732.
    • (1977) Nature , vol.266 , pp. 730-732
    • Porsolt, R.D.1    Le Pichon, M.2    Jalfre, M.3
  • 136
    • 1842420631 scopus 로고    scopus 로고
    • Rapid antidepressive-like activity of specific glycogen synthase kinase-3 inhibitor and its effect on beta-catenin in mouse hippocampus
    • Kaidanovich-Beilin O., Milman A., Weizman A., Pick C.G., Eldar-Finkelman H. (2004). Rapid antidepressive-like activity of specific glycogen synthase kinase-3 inhibitor and its effect on beta-catenin in mouse hippocampus. Biol. Psychiat., 55, 781-784.
    • (2004) Biol. Psychiat. , vol.55 , pp. 781-784
    • Kaidanovich-Beilin, O.1    Milman, A.2    Weizman, A.3    Pick, C.G.4    Eldar-Finkelman, H.5
  • 137
    • 0035872392 scopus 로고    scopus 로고
    • Antidepressantlike properties of zinc in rodent forced swim test
    • Kroczka B., Branski P., Palucha A., Pilc A., Nowak G. (2001). Antidepressantlike properties of zinc in rodent forced swim test. Brain Res. Bull., 55, 297-300.
    • (2001) Brain Res. Bull. , vol.55 , pp. 297-300
    • Kroczka, B.1    Branski, P.2    Palucha, A.3    Pilc, A.4    Nowak, G.5
  • 138
    • 0037707701 scopus 로고    scopus 로고
    • Antidepressant-like effects of acute and chronic treatment with zinc in forced swim test and olfactory bulbectomy model in rats
    • Nowak G., Szewczyk B., Wieronska J.M., Branski P., Palucha A., Pilc A., Sadlik K., Piekoszewski W. (2003). Antidepressant-like effects of acute and chronic treatment with zinc in forced swim test and olfactory bulbectomy model in rats. Brain Res. Bull., 61, 159-164.
    • (2003) Brain Res. Bull. , vol.61 , pp. 159-164
    • Nowak, G.1    Szewczyk, B.2    Wieronska, J.M.3    Branski, P.4    Palucha, A.5    Pilc, A.6    Sadlik, K.7    Piekoszewski, W.8
  • 139
    • 0033665173 scopus 로고    scopus 로고
    • Zinc exhibits an antidepressant-like effect in the forced swimming test in mice
    • Kroczka B., Zieba A., Dudek D., Pilc A., Nowak G. (2000). Zinc exhibits an antidepressant-like effect in the forced swimming test in mice. Pol. J. Pharmacol., 52, 403-406.
    • (2000) Pol. J. Pharmacol. , vol.52 , pp. 403-406
    • Kroczka, B.1    Zieba, A.2    Dudek, D.3    Pilc, A.4    Nowak, G.5
  • 142
    • 1642503034 scopus 로고    scopus 로고
    • Effect of zinc supplementation on antidepressant therapy in unipolar depression: A preliminary placebo-controlled study
    • Nowak G., Siwek M., Dudek D., Zieba A., Pilc A. (2003). Effect of zinc supplementation on antidepressant therapy in unipolar depression: A preliminary placebo-controlled study. Pol. J. Pharmacol., 55, 1143-1147.
    • (2003) Pol. J. Pharmacol. , vol.55 , pp. 1143-1147
    • Nowak, G.1    Siwek, M.2    Dudek, D.3    Zieba, A.4    Pilc, A.5
  • 144
    • 20544437694 scopus 로고    scopus 로고
    • Glycogen synthase kinase-3: A putative molecular target for lithium mimetic drugs
    • Gould T.D., Manji H.K. (2005). Glycogen synthase kinase-3: A putative molecular target for lithium mimetic drugs. Neuropsychopharmacology, 30, 1223-1237.
    • (2005) Neuropsychopharmacology , vol.30 , pp. 1223-1237
    • Gould, T.D.1    Manji, H.K.2
  • 145
    • 0036090823 scopus 로고    scopus 로고
    • Glycogen synthase kinase 3: An emerging therapeutic target
    • Eldar-Finkelman H. (2002). Glycogen synthase kinase 3: An emerging therapeutic target. Trends Mol. Med., 8, 126-132.
    • (2002) Trends Mol. Med. , vol.8 , pp. 126-132
    • Eldar-Finkelman, H.1
  • 146
    • 3042635178 scopus 로고    scopus 로고
    • GSK-3 inhibitors: Development and therapeutic potential
    • Cohen P., Goedert M. (2004). GSK-3 inhibitors: Development and therapeutic potential. Nat. Rev. Drug. Discov., 3, 479-487.
    • (2004) Nat. Rev. Drug. Discov. , vol.3 , pp. 479-487
    • Cohen, P.1    Goedert, M.2
  • 147
    • 0036273020 scopus 로고    scopus 로고
    • Glycogen synthase kinase 3 (GSK-3) inhibitors as new promising drugs for diabetes, neurodegeneration, cancer, and inflammation
    • Martinez A., Castro A., Dorronsoro I., Alonso M. (2002). Glycogen synthase kinase 3 (GSK-3) inhibitors as new promising drugs for diabetes, neurodegeneration, cancer, and inflammation. Med. Res. Rev., 22, 373-384.
    • (2002) Med. Res. Rev. , vol.22 , pp. 373-384
    • Martinez, A.1    Castro, A.2    Dorronsoro, I.3    Alonso, M.4
  • 149
    • 0037075791 scopus 로고    scopus 로고
    • First non-ATP competitive glycogen synthase kinase 3 beta (GSK-3beta) inhibitors: Thiadiazolidinones (TDZD) as potential drugs for the treatment of Alzheimer's disease
    • Martínez A., Alonso M., Castro A., Perez C., Moreno F.J. (2002). First non-ATP competitive glycogen synthase kinase 3 beta (GSK-3beta) inhibitors: Thiadiazolidinones (TDZD) as potential drugs for the treatment of Alzheimer's disease. J. Med. Chem., 45, 1292-1299.
    • (2002) J. Med. Chem. , vol.45 , pp. 1292-1299
    • Martínez, A.1    Alonso, M.2    Castro, A.3    Perez, C.4    Moreno, F.J.5
  • 150
    • 0038811796 scopus 로고    scopus 로고
    • Insulin mimetic action of synthetic phosphorylated peptide inhibitors of glycogen synthase kinase-3
    • Plotkin B., Kaidanovich O., Talior I., Eldar-Finkelman H. (2003). Insulin mimetic action of synthetic phosphorylated peptide inhibitors of glycogen synthase kinase-3. J Pharmacol. Exp. Ther., 305, 974-980.
    • (2003) J Pharmacol. Exp. Ther. , vol.305 , pp. 974-980
    • Plotkin, B.1    Kaidanovich, O.2    Talior, I.3    Eldar-Finkelman, H.4
  • 151
    • 1442284539 scopus 로고    scopus 로고
    • Glycogen synthase kinase-3: A target for novel bipolar disorder treatments
    • Gould T.D., Zarate C.A., Manji H.K. (2004). Glycogen synthase kinase-3: A target for novel bipolar disorder treatments. J. Clin. Psychiat., 65, 10-21.
    • (2004) J. Clin. Psychiat. , vol.65 , pp. 10-21
    • Gould, T.D.1    Zarate, C.A.2    Manji, H.K.3
  • 153
    • 20544437694 scopus 로고    scopus 로고
    • Glycogen synthase kinase-3: A putative molecular target for lithium mimetic drugs
    • in press
    • Gould T.D., Manji, H.K. (2005). Glycogen synthase kinase-3: A putative molecular target for lithium mimetic drugs. Neuropsychopharmacology (in press).
    • (2005) Neuropsychopharmacology
    • Gould, T.D.1    Manji, H.K.2
  • 154
    • 84889353697 scopus 로고    scopus 로고
    • Antipsychotics alter the protein expression levels of b-catenin and GSK-3 in the rat medial prefrontal cortex and striatum
    • in press
    • Alimohamad H., Rajakumar N., Seah Y.H., Rushlow W. (in press). Antipsychotics alter the protein expression levels of b-catenin and GSK-3 in the rat medial prefrontal cortex and striatum. Biol. Psychiat.
    • Biol. Psychiat
    • Alimohamad, H.1    Rajakumar, N.2    Seah, Y.H.3    Rushlow, W.4
  • 156
    • 10644255687 scopus 로고    scopus 로고
    • AR-A014418, a selective GSK-3 inhibitor, produces antidepressant-like effects in the forced swim test
    • Gould T.D., Einat H., Bhat R., Manji H.K. (2004). AR-A014418, a selective GSK-3 inhibitor, produces antidepressant-like effects in the forced swim test. Int. J. Neuropsychopharmacol., 1-4.
    • (2004) Int. J. Neuropsychopharmacol. , pp. 1-4
    • Gould, T.D.1    Einat, H.2    Bhat, R.3    Manji, H.K.4
  • 157
    • 0038187674 scopus 로고    scopus 로고
    • GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides
    • Phiel C.J., Wilson C.A., Lee V.M., Klein P.S. (2003). GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides. Nature, 423, 435-439.
    • (2003) Nature , vol.423 , pp. 435-439
    • Phiel, C.J.1    Wilson, C.A.2    Lee, V.M.3    Klein, P.S.4
  • 158
    • 0242720372 scopus 로고    scopus 로고
    • Chronic lithium treatment decreases mutant tau protein aggregation in a transgenic mouse model
    • Perez M., Hernandez F., Lim F., Díaz-Nido J., Avila J. (2003). Chronic lithium treatment decreases mutant tau protein aggregation in a transgenic mouse model. J. Alzheimers Dis., 5, 301-308.
    • (2003) J. Alzheimers Dis. , vol.5 , pp. 301-308
    • Perez, M.1    Hernandez, F.2    Lim, F.3    Díaz-Nido, J.4    Avila, J.5
  • 159
    • 2642552331 scopus 로고    scopus 로고
    • Lithium, a common drug for bipolar disorder treatment, regulates amyloid-beta precursor protein processing
    • Su Y., Ryder J., Li B., Wu X., Fox N., Solenberg P., Brune K., Paul S., Zhou Y., Liu F., Ni B. (2004). Lithium, a common drug for bipolar disorder treatment, regulates amyloid-beta precursor protein processing. Biochemistry, 43, 6899-6908.
    • (2004) Biochemistry , vol.43 , pp. 6899-6908
    • Su, Y.1    Ryder, J.2    Li, B.3    Wu, X.4    Fox, N.5    Solenberg, P.6    Brune, K.7    Paul, S.8    Zhou, Y.9    Liu, F.10    Ni, B.11


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.